Brokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $39.14
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are presently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month price […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are presently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month price […]
